Novo Nordisk to cut US insulin prices by up to 75%

Novo Nordisk announced Tuesday that it will lower the US price of insulin by up to 75 percent, the latest move by a drugmaker to mitigate diabetes treatment costs.

Leave A Comment

Your email address will not be published. Required fields are marked *